Related Experiment Videos
Challenges for biomarkers in cancer detection
Paul D Wagner1, Mukesh Verma, Sudhir Srivastava
1Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-7346, USA.
Annals of the New York Academy of Sciences
|July 15, 2004
Summary
Biomarkers are crucial for early cancer detection and monitoring disease progression. Advances in technology are enabling the development of sensitive, noninvasive biomarkers for timely cancer diagnosis.
Area of Science:
- Oncology
- Biomarker Discovery
- Cancer Diagnostics
Background:
- Cancer is a leading cause of mortality in the United States.
- Biomarkers play a vital role in cancer detection across all disease stages.
- Effective biomarkers offer early indications of cancer progression.
Purpose of the Study:
- To highlight the importance of biomarkers in cancer detection.
- To discuss the desirable characteristics of cancer biomarkers.
- To review technological advancements in biomarker development.
Main Methods:
- Literature review on cancer biomarkers.
- Analysis of biomarker utility in early detection, risk assessment, recurrence monitoring, and intervention studies.
- Discussion of recent technological innovations.
Main Results:
- Biomarkers are essential for identifying cancer at initiation, development, and progression stages.
- Ideal biomarkers are easily detectable, measurable, and provide early disease indications.
- Technological progress facilitates the creation of noninvasive, sensitive, and specific biomarkers.
Conclusions:
- Biomarkers are indispensable tools in the fight against cancer.
- The development of advanced biomarkers is key to improving patient outcomes.
- Noninvasive, sensitive, and specific biomarkers enable earlier cancer detection and management.